PFE
Pfizer Inc
Price:  
27.82 
USD
Volume:  
24,164,258.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Pfizer Relative Valuation

-130.1%
Upside

As of 2024-05-30, the Relative Valuation of Pfizer Inc (PFE) is (8.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.82 USD, the upside of Pfizer Inc based on Relative Valuation is -130.1%.

The range of the Relative Valuation is (21.82) - 9.36 USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 24.6x - 30.9x 28.8x
Forward P/E multiples 23.0x - 27.8x 25.8x
Fair Price (21.82) - 9.36 (8.38)
Upside -178.4% - -66.3% -130.1%
27.82 USD
Stock Price
(8.38) USD
Fair Price

Pfizer Relative Valuation - Historical P/E Data

Date P/E
2024-05-29 -31.42
2024-05-28 -31.96
2024-05-24 -32.61
2024-05-23 -32.40
2024-05-22 -33.43
2024-05-21 -32.25
2024-05-20 -32.22
2024-05-17 -32.34
2024-05-16 -32.66
2024-05-15 -32.55
2024-05-14 -32.05
2024-05-13 -32.12
2024-05-10 -31.63
2024-05-09 -31.82
2024-05-08 -31.92
2024-05-07 -31.36
2024-05-06 -31.80
2024-05-03 -31.40
2024-05-02 -31.28
2024-05-01 -30.69
2024-04-30 -28.93
2024-04-29 -28.95
2024-04-26 -28.68
2024-04-25 -28.52
2024-04-24 -29.67
2024-04-23 -29.72
2024-04-22 -29.65
2024-04-19 -29.36
2024-04-18 -28.67
2024-04-17 -28.71
2024-04-16 -29.01
2024-04-15 -29.26
2024-04-12 -29.20
2024-04-11 -29.74
2024-04-10 -29.72
2024-04-09 -30.24
2024-04-08 -30.02
2024-04-05 -30.11
2024-04-04 -30.09
2024-04-03 -30.74
2024-04-02 -31.11
2024-04-01 -31.30
2024-03-28 -31.34
2024-03-27 -31.37
2024-03-26 -31.16
2024-03-25 -30.98
2024-03-22 -30.90
2024-03-21 -31.24
2024-03-20 -31.28
2024-03-19 -31.20